Citation:Kastelein F, Spaander MC, Steyerberg EW, Biermann K, Valkhoff VE, Kuipers EJ et al 2012

From Cancer Guidelines Wiki

Citation


Kastelein F, Spaander MC, Steyerberg EW, Biermann K, Valkhoff VE, Kuipers EJ et al. Proton Pump Inhibitors Reduce the Risk of Neoplastic Progression in Patients with Barrett's Esophagus. Clin Gastroenterol Hepatol 2012 Nov 27 Abstract available at http://www.ncbi.nlm.nih.gov/pubmed/23200977.



Critical appraisals

Critical appraisal linkClinical questionAssigned toStatus
Are there any treatments that prevent progression of BO to cancer?Professor David Watson MBBS, MD, FRACScompleted
Are there any medical or surgical interventions that cause regression of BO?Dr Adrian Chung MBBS, BMed Sci, FRACPpending
Are there groups of patients with non-dysplastic BO that require more frequent surveillance?Dr Henry Tocompleted
Are there groups of patients with BO that can be discharged from surveillance?Conjoint Associate Professor Philip Craigcompleted
What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?Professor David Whiteman B Med Sci, MBBS (Hons) PhD FAFPHMcompleted

Compare quality appraisals for each clinical question

Cited by

  1. What are the risk factors for progression from non-dysplastic BO to high-grade dysplasia or adenocarcinoma?